AML cytogenetics risk stratification Flashcards
1
Q
t(8;21); RUNX1-RUNX1T1
A
Favorable
2
Q
inv(16) or t(16;16); CBFB-MYH11
A
Favorable
3
Q
Mutated NPM1 with WT FLT3-ITD
A
Favorable
4
Q
Biallelic mutated CEBP
A
Favorable
5
Q
t(6;9); DEK-NUP214
A
Adverse
6
Q
t(v;11); KTM2A rearranged
A
Adverse
7
Q
t(9;22); BCR-ABL1
A
Adverse
8
Q
inv(3) or t(3;3)
A
Adverse
9
Q
Mutated RUNX1
A
Adverse
10
Q
Mutated ASKL1
A
Adverse
11
Q
Mutated TP53
A
Adverse
12
Q
Mutated NPM1 and mutated FLT3-ITD
A
Intermediate
13
Q
WT NPM1 and mutated FLT3-ITD
A
Adverse
